Status:
COMPLETED
Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty
Lead Sponsor:
JIANG Qing
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
35-90 years
Phase:
PHASE2
PHASE3
Brief Summary
Deep vein thrombosis (DVT) remains a life-threatening complication of arthroplasty. It remains controversial for anticoagulation strategies after total hip arthroplasty (THA). A randomized double-blin...
Eligibility Criteria
Inclusion
- Primary total hip arthroplasty
Exclusion
- Revision hip replacement, total knee replacement, revision knee replacement, semi-hip replacement and cemented THR were excluded.
- Coagulation related disease and cancer were excluded either.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
February 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01446887
Start Date
January 1 2007
End Date
February 1 2011
Last Update
October 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Center of Diagnosis and Treatment for Joint Disease, Drum Tower Hospital
Nanjing, Jiangsu, China, 210008